MIT spinout Leuko has developed PointCheck, a medical device that non-invasively measures white blood cells from a patient's home. PointCheck has potential to improve clinical outcomes and reduce ...

BOSTON--(BUSINESS WIRE)--Leuko, a medtech company pioneering the field of non-invasive blood testing, announced today that it has received a $4.5 million SBIR Phase IIB award from the National ...

Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020 Leuko, founded by researchers at the Massachusetts Institute of Technology (MIT), has developed an at-home white ...

BOSTON--(BUSINESS WIRE)--Leuko, an MIT-born technology startup developing the first non-invasive white blood cell monitoring device, today announced it has raised $1.8 million in seed financing ...

MIT spin-out is developing a microscope platform for label-free imaging of human blood cells as they flow through capillaries. Leuko, a startup company established by researchers at the Massachusetts ...